Martin P. Schrama is a Shareholder in Stark & Stark's Commercial Litigation, Mass Tort, Intellectual Property and Green Litigation Groups. Mr. Schrama has extensive experience litigating on both the trial and appellate levels of the federal and state courts of New Jersey and New York, as well as numerous other jurisdictions throughout the nation in a pro hac vice capacity. This experience also extends to regular practice before AAA, JAMS and various other alternate dispute resolution fora.
The primary focus of Mr. Schrama’s practice is complex civil litigation matters, with a concentration in mass tort/class action prosecution and defense, and complex commercial litigation. Mr. Schrama is currently co-lead trial counsel representing numerous plaintiffs in the mass tort environmental contamination case of In Re Bristol-Myers Squibb Environmental Contamination Litigation, Case No. 281. Mr. Schrama is also currently involved in representing numerous plaintiffs in mass tort pharmaceutical cases pending in the New Jersey Superior Court case of In Re Yaz®, Yasmin®, and Ocella® Litigation, Case No. 287; In Re Nuvaring® Litigation, Case No. 284; and In Re Depuy ASR® Hip Implants Litigation, Case No. 293. Mr. Schrama frequently writes about timely legal and legislative developments impacting plaintiffs in mass tort and product liability actions for Stark & Stark's Mass Tort Law Blog.
